综上所述，多西他赛联合阿帕替尼二线治疗进展期NSCLC的效果显著，可改善患者生活质量，可有效阻止疾病进展，且安全性较好。

    [参考文献]

    [1] Pujol JL，Roch B. Is Darbepoietin Alfa Linked to Mortality During Non-Small Cell Lung Cancer Chemotherapy？ [J]. J Thorac Oncol，2020，15(2)：159-162.

    [2] Vaidya P，Bera K，Gupta A，et al. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in StageⅠ，Ⅱ resectable Non-Small Cell Lung Cancer： a retrospective multi-cohort study for outcome prediction [J]. Lancet Digit Health ......